BRETT C. SHEPPARD, MD
Radiology at Sam Jackson Park Rd, Portland, OR
License number
Oregon MD14486
Category
Radiology
Type
Surgery
Address
Address
3181 SW Sam Jackson Park Rd, Portland, OR 97239
Phone
(503) 494-6900
(503) 494-8884 (Fax)
(503) 494-8884 (Fax)
Personal information
See more information about BRETT C. SHEPPARD at radaris.comName
Address
Phone
2887 NW Westover Rd, Portland, OR 97210
2887 Westover Rd, Portland, OR 97210
3181 Sam Jackson Park Rd, Portland, OR 97239
8 Science University, Portland, OR 97201
Professional information
Professor Of Surgery At Ohsu
Location:
Portland, Oregon Area
Industry:
Hospital & Health Care
Dr. Brett C Sheppard, Portland OR - MD (Doctor of Medicine)
Specialties:
Critical Care Surgery
Address:
Digestive Health Center
3303 SW Bond Ave, Portland 97239
(503) 494-4373 (Phone)
3303 SW Bond Ave, Portland 97239
(503) 494-4373 (Phone)
Certifications:
Critical Care Surgery, 1992, General Surgery, 2010
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Rosalind Franklin University Of Medicine Science/The Chicago Medical School
Graduated: 1984
Oregon Health Sciences University
Graduated: 1985
Graduated: 1991
Nih/Nci
Graduated: 1989
Rosalind Franklin University Of Medicine Science/The Chicago Medical School
Graduated: 1984
Oregon Health Sciences University
Graduated: 1985
Graduated: 1991
Nih/Nci
Graduated: 1989
Monoclonal Antibodies Specific For Pancreatic Neoplasia Cells
US Patent:
2011017, Jul 14, 2011
Filed:
Sep 9, 2009
Appl. No.:
13/062942
Inventors:
Phillip R. Streeter - Portland OR, US
Markus Grompe - Portland OR, US
Karin M. Hardiman - Portland OR, US
Brett C. Sheppard - Portland OR, US
Christopher L. Corless - Portland OR, US
Terry K. Morgan - Portland OR, US
Markus Grompe - Portland OR, US
Karin M. Hardiman - Portland OR, US
Brett C. Sheppard - Portland OR, US
Christopher L. Corless - Portland OR, US
Terry K. Morgan - Portland OR, US
International Classification:
A61K 39/395, G01N 33/53, C12N 9/96, C12N 5/10, C12N 5/16, C12N 5/02, C12N 15/63, C07K 16/18, C07H 21/04
US Classification:
4241331, 4241411, 435 71, 435188, 435325, 435326, 435375, 435378, 4353201, 5303873, 5303881, 5303913, 5303917, 536 2353
Abstract:
Isolated monoclonal antibodies are disclosed herein that specifically bind a cell surface antigen expressed on the human pancreatic cancer cells or precancerous pancreatic cancer cells. Humanized forms of these antibodies, functional fragments of these antibodies, and hybridomas producing these antibodies are also disclosed. The antibodies can be conjugated to an effector molecule, such as a detectable marker, a therapeutic agent, or a toxin. The antibodies can be used for in vitro or in vivo pancreatic cancer diagnosis or disease monitoring via detection of pancreatic cancer cells or the pancreatic cancer cell surface antigen. Methods of treating a pancreatic cancer by administration of the antibodies are also disclosed.